Predictive Value of HbA1c and Metabolic Syndrome for Renal Outcome in Non-Diabetic CKD Stage 1–4 Patients

Glycated hemoglobin (HbA1c) levels are commonly used to indicate long-term glycemic control. An HbA1c level of 6.5–5.7% is defined as pre-diabetes and is proposed as a criterion for diagnosing metabolic syndrome (MetS). However, HbA1c levels can be affected by chronic kidney disease (CKD). Whether H...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Chi-Chih, Zhen, Yen-Yi, Niu, Sheng-Wen, Lin, Kun-Der, Lin, Hugo You-Hsien, Lee, Jia-Jung, Chang, Jer-Ming, Kuo, I-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404918/
https://www.ncbi.nlm.nih.gov/pubmed/36009406
http://dx.doi.org/10.3390/biomedicines10081858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404918/
https://www.ncbi.nlm.nih.gov/pubmed/36009406
http://dx.doi.org/10.3390/biomedicines10081858

Ejemplares similares